|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| C07D 487/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2528625 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11716146.3 |
| Date of filing the European patent application | 2011-04-15 | |
| (97) | Date of publication of the European application | 2012-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-10 |
| (46) | Date of publication of the claims translation | 2013-11-25 |
| (86) | Number | PCT/US2011/032632 |
| Date | 2011-04-15 |
| (87) | Number | WO 2011/130598 |
| Date | 2011-10-20 |
| (30) | Number | Date | Country code |
| 201016802 | 2010-10-06 | GB | |
| 201006341 | 2010-04-15 | GB |
| (72) |
HOWARD, Philip, Wilson, GB
MASTERSON, Luke, GB
TIBERGHIEN, Arnaud, GB
FLYGARE, John, A., US
GUNZNER, Janet, L., US
POLAKIS, Paul, US
POLSON, Andrew, US
RAAB, Helga, E., US
SPENCER, Susan, D., US
|
| (73) |
MEDIMMUNE LIMITED,
Milstein Building, Granta Park, Cambridge CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepinai ir jų konjugatai |
| PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-03-20 | 16 | 347.00 EUR |
| 2027-04-15 |